Fisher & Paykel Healthcare (NZSE:FPH) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 24, 2026)


NZSE:FPH Fisher & Paykel Healthcare Corp Ltd NZSE:FPH
91 GF Score
Price NZ$37.50
GF Value NZ$44.33
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Fisher & Paykel Healthcare Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Fisher & Paykel Healthcare's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

NZSE:FPH vs ISRG, BDX, MDLN: Margin of Safety % (DCF Earnings Based) Comparison

For the Medical Instruments & Supplies subindustry, Fisher & Paykel Healthcare's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fisher & Paykel Healthcare Margin of Safety % (DCF Earnings Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Fisher & Paykel Healthcare's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Fisher & Paykel Healthcare's Margin of Safety % (DCF Earnings Based) falls into.


NZSE:FPH
91GF Score
Fisher & Paykel Healthcare Corp Ltd NZSE:FPH
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Fisher & Paykel Healthcare (NZSE:FPH) Overvalued in 2026?

Based on GuruFocus' analysis, Fisher & Paykel Healthcare stock appears to be undervalued. The current stock price of NZ$37.50 is trading 15.4% below its estimated GF Value™ of NZ$44.33. GuruFocus considers Fisher & Paykel Healthcare to be Modestly Undervalued.

Key valuation signals for NZSE:FPH:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: NZ$44.33 vs. price of NZ$37.50 (15.4% below fair value)
  • GF Score™: 91/100 with 3 warning signs

No single metric tells the full story. See the NZSE:FPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fisher & Paykel Healthcare Business Description

Other Exchanges FSPKF:USAFPH:Australia
Address 15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use of humidifiers, masks, and related consumables, and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns roughly half of its revenue in North America, around a quarter in Europe, and approximately a fifth in Asia-Pacific. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand, Mexico, and China, and has a multichannel distribution model.
91GF Score

Get the complete analysis for NZSE:FPH

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NZ$37.50
Price
NZ$44.33
GF Value